Table: Chugai Pharm -2018 group results (IFRS)

Chugai Pharmaceutical

31/01/2019 08:00

Jan 31 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to        NEXT  
                Dec 31, 2018    Dec 31, 2017   Dec 31, 2019      YEAR    
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULT        FORECAST    H1 FORECAST 
  Sales            579.79          534.20                                
                 (+8.5 pct)      (+8.6 pct)                              
  Operating        124.32           98.93                                
                 (+25.7 pct)     (+28.7 pct)                             
  Pretax
  Net               92.49           72.71                                
                 (+27.2 pct)     (+35.7 pct)                             
  EPS Basic      169.08 yen      133.04 yen                              
  EPS Diluted    168.80 yen      132.83 yen                              
  Ann Div         86.00 yen       62.00 yen      96.00 yen               
  -Q2 Div         31.00 yen       29.00 yen      48.00 yen               
  -Q4 Div         55.00 yen       33.00 yen      48.00 yen               
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T